We were delighted to speak with Prof. Donald Mahler (Geisel School of Medicine, Dartmouth, NH, USA) to explore his presentation ‘Precision Medicine in COPD’, which was presented at CHEST 2021, 17-20 October 2021.
Questions
- What is the limitation of traditional approaches to the treatment of COPD? (0:26)
- What are the major challenges of moving to precision medicine in COPD? (1:46)
- What are the most promising emerging predictive biomarkers in COPD? (2:53)
- What other clinical features can guide therapeutic choice in COPD? (5:08)
- What is the current status of precision medicine in COPD and how do you envisage this field developing in the coming years? (6:22)
Disclosures: Donald Mahler has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of CHEST 2021 (Virtual).
For further information please visit Prof. Mahler’s website here: https://www.donaldmahler.com.
